Trimming the Fat in the Treatment of Prostate Cancer (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Trimming the Fat in the Treatment of Prostate Cancer (1 of 2)

Caption

Silencing the expression of the Cd36 protein (shCD36) reduced cell migration and impaired aggressiveness in PC3 prostate cancer cells. This material relates to a paper that appeared in the Feb. 06, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by M.J. Watt at University of Melbourne in Melbourne, VIC, Australia; and colleagues was titled, "Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer."

Credit

M.J. Watt <i>et al., Science Translational Medicine </i>(2018)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.